The Successful Management of COVID-19 Patient with Severe ARDS Using Standard Therapy
Abstract
Keywords
Full Text:
PDF (Bahasa Indonesia)References
Instiaty, Darmayani I, Marzuki J, Angelia F, William, Siane A, et al. Antiviral treatment of COVID-19: a clinical pharmacology narrative review. Med J Indones. 2020; 29(3):332-45.
Wasityastuti W, Dhamarjati A, Siswanto. Imunosenesens dan Kerentanan Populasi Usia Lanjut Terhadap Coronavirus Disease 2019 (COVID-19). J Respir Indo. 2020; 40(3):182-91.
Kazory A, Ronco C, McCullough PA. SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill. Baylor University Medical Center Proceedings. 2020;: p. 370-375.
Smith T, Bushek J, LeClaire A, Prosser T. COVID-19 Drug Therapy. Elsevier Clinical Drug Information. 2020.
Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020; 27(5):1451-4.
Walter LA, McGregor AJ. Sex- and Gender-specific Observations and Implications for COVID-19. West J Emerg Med. 2020; 21(3):507-9.
Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020; 57:279-83.
Vahedi E, Ghanei M, Ghazvini A, Azadi H, M I, Panahi Y, et al. The clinical value of two combination regimens in the management fo patients suffering from COVID-19 pneumonia: a single centered, retrospective, obserational study. DARU J Pharm Sci. 2020; 28:507-16.
Poschet J, Perkett E, Timmins G, Deretic V. Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory ephitelial cells. bioRxiv. 2020. Preprint.
Bleyzac N, Goutelle S, Bourguignon L, Tod M. Azithromycin for COVID-19: More than just an antimicrobial? Clinical Drug Investigation. 2020.
Rodvold K, Gorfried M, Danziger L, Servi R. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antrimicrob Agnet Chemother. 1997; 41: p. 1399-1402.
Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020; 46(6):1099-102.
Boissier F, Razazi K, Seenann A, Bedet A, Thille A, de Prost N, et al. Left ventricular systolic dysfunction during septic shock: the role of loading conditions. Intensive Care Med. 2017; 45(3):633-42.
Cheung K, Hung IFN, Chan PP, et.al.. Gastrointestinal manifestation of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong court: systematic review and meta-analysis. Gastroenterology. 2020; 159(1):81-95.
Kaafarani HM, Moheb ME, Velmahos GC. Gastrointestinal complications in critically ill patients with COVID-19. Ann Surg. 2020; 272(2):61-2.
Boretti A, Banik BK. Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrom. PharmaNutrition. 2020;: p. 12.
Liu Q, Gao Y, Ci X. Role of Nrf2 and its activators in respiratory diseases. Oxid. Med. Cell. Longev. 2019:7090534.
Gonzales MJ, al. e. High dose vitamin C and influenza: a case report. J. Orthomol. Med. 2018; 3:33.
Feyaerts AF, Luyten W. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition. 2020; 79:110948.
Barrett C, Moore H, Yaffe M, Moore E. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment. J Thromb Haemost. 2020; 18(8):2060-3.
Shi C, Wang C, Wang H, Yang C, Cai F, Zeng F, et al. The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study. medRxiv. 2020; 13(6):1087-95.
Hippensteel JA, LaRiviere WB, Colbert JF, Langouet-Astrie CJ, Schmidt EP. Heparin as a therapy for COVID-19: current evidence amd future possibilities. Am J Physiol Lung Cell Mol Physiol. 2020; 319(2):211-7.
Gozzo L, Viale P, Longo L, Vitale DC, Filippo D. The potential role of heparin in patients with COVID-19: beyond the anticoagulant effect. A review. Front. Pharmacol. 2020; 11:1307.
Prescott HC, Rice TW. Corticosteroids in COVID-19 ARDS. Journal of American Medical Association. 2020; 324(13):1292-5.
Zheng C, Wang J, Guo H, Lu Z, Ma Y, Zhu Y, et al. Risk-adapted treatment strategy for COVID-19 patients. Int J Infect Dis. 2020; 94:74-7.
DOI: https://doi.org/10.36497/jri.v41i2.170
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Dian Indriani Hidayat, Sofyan Budi Raharjo
INDEXING & PARTNER
Jurnal Respirologi Indonesia pISSN: 0853-7704 - eISSN: 2620-3162 Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia Phone: +62-21-2247-4845 Email: editor@jurnalrespirologi.org | An official publication by the Indonesian Society of Respirology (ISR) |
Creative Commons Attribution-ShareAlike 4.0 International License Statcounter |